ES499377A0 - Un procedimiento para la preparacion de nuevos derivados de piperazinilquinazolina y de homopiperazinilquinazolina hi- pertensora con acticidad. - Google Patents

Un procedimiento para la preparacion de nuevos derivados de piperazinilquinazolina y de homopiperazinilquinazolina hi- pertensora con acticidad.

Info

Publication number
ES499377A0
ES499377A0 ES499377A ES499377A ES499377A0 ES 499377 A0 ES499377 A0 ES 499377A0 ES 499377 A ES499377 A ES 499377A ES 499377 A ES499377 A ES 499377A ES 499377 A0 ES499377 A0 ES 499377A0
Authority
ES
Spain
Prior art keywords
piperazinilquinazolina
homopiperazinilquinazolina
acticity
hypertensive
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES499377A
Other languages
English (en)
Spanish (es)
Other versions
ES8207169A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP1677580A external-priority patent/JPS56113770A/ja
Priority claimed from JP5275480A external-priority patent/JPS56150072A/ja
Priority claimed from JP9610680A external-priority patent/JPS5721384A/ja
Priority claimed from JP9610780A external-priority patent/JPS5721385A/ja
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of ES8207169A1 publication Critical patent/ES8207169A1/es
Publication of ES499377A0 publication Critical patent/ES499377A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES499377A 1980-02-13 1981-02-12 Un procedimiento para la preparacion de nuevos derivados de piperazinilquinazolina y de homopiperazinilquinazolina hi- pertensora con acticidad. Granted ES499377A0 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP1677580A JPS56113770A (en) 1980-02-13 1980-02-13 Novel quinazoline derivative and its preparation
JP5275480A JPS56150072A (en) 1980-04-21 1980-04-21 Novel quinazoline derivative and its preparation
JP9610680A JPS5721384A (en) 1980-07-14 1980-07-14 Novel aminoquinazoline derivative and its preparation
JP9610780A JPS5721385A (en) 1980-07-14 1980-07-14 Novel aminoquinazoline derivative and its preparation

Publications (2)

Publication Number Publication Date
ES8207169A1 ES8207169A1 (es) 1982-09-01
ES499377A0 true ES499377A0 (es) 1982-09-01

Family

ID=27456647

Family Applications (1)

Application Number Title Priority Date Filing Date
ES499377A Granted ES499377A0 (es) 1980-02-13 1981-02-12 Un procedimiento para la preparacion de nuevos derivados de piperazinilquinazolina y de homopiperazinilquinazolina hi- pertensora con acticidad.

Country Status (9)

Country Link
US (1) US4426382A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1154765A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH644857A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3105330A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES499377A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2475548A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2068961B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1172225B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL191208C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS236097B1 (en) * 1983-06-01 1985-05-15 Jan Koenig Acylderivatives of 2-piperazinochinazoline and method of their preparation
DE3346675A1 (de) * 1983-12-23 1985-07-04 Beiersdorf Ag, 2000 Hamburg Substituierte 1-(4-amino-6,7-dialkoxy-chinazolinyl)-4- cyclohexenyl-derivate des piperazins und homopiperazins, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen und zwischenprodukte
JPH0647540B2 (ja) * 1985-07-16 1994-06-22 エーザイ株式会社 虚血性心疾患・不整脈治療・予防剤
IT1270993B (it) * 1994-03-18 1997-05-26 Recordati Chem Pharm Derivati chinzolilamminici attivi come alfa-antagonisti
TWI350168B (en) * 2004-05-07 2011-10-11 Incyte Corp Amido compounds and their use as pharmaceuticals
AU2007245037A1 (en) * 2006-03-29 2007-11-08 Merck Sharp & Dohme Corp. Diazepan orexin receptor antagonists
PE20081229A1 (es) * 2006-12-01 2008-08-28 Merck & Co Inc Antagonistas de receptor de orexina de diazepam sustituido
WO2008145681A2 (en) 2007-05-31 2008-12-04 Boehringer Ingelheim International Gmbh Ccr2 receptor antagonists and uses thereof
WO2009143404A1 (en) * 2008-05-23 2009-11-26 Wyeth Piperazine metabotropic glutamate receptor 5 (mglur5) negative allosteric modulators for anxiety/depression
WO2010070032A1 (en) 2008-12-19 2010-06-24 Boehringer Ingelheim International Gmbh Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
PL2513093T3 (pl) 2009-12-17 2015-03-31 Centrexion Therapeutics Corp Nowi antagoniści receptora CCR2 i ich zastosowanie
WO2011141474A1 (en) 2010-05-12 2011-11-17 Boehringer Ingelheim International Gmbh Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
WO2011141477A1 (en) 2010-05-12 2011-11-17 Boehringer Ingelheim International Gmbh New ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
US8841313B2 (en) 2010-05-17 2014-09-23 Boehringer Ingelheim International Gmbh CCR2 antagonists and uses thereof
US9018212B2 (en) 2010-05-25 2015-04-28 Boehringer Ingelheim International Gmbh Pyridazine carboxamides as CCR2 receptor antagonists
EP2576538B1 (en) 2010-06-01 2015-10-28 Boehringer Ingelheim International GmbH New CCR2 antagonists
JP5786258B2 (ja) 2011-07-15 2015-09-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規かつ選択的なｃｃｒ２拮抗薬
AU2013241854B2 (en) * 2012-03-28 2017-11-02 Intervet International B.V. Heteroaryl compounds with cyclic bridging unit for use in the treatment helminth infection
KR20150033652A (ko) 2012-06-20 2015-04-01 노파르티스 아게 보체 경로 조절제 및 그의 용도
WO2015095111A1 (en) 2013-12-18 2015-06-25 Merck Sharp & Dohme Corp. Diazepane orexin receptor antagonists
MX383744B (es) 2015-07-02 2025-03-14 Centrexion Therapeutics Corp Citrato de (4-((3r,4r)-3-metoxitetrahidro-piran-4-ilamino)piperidin-1-il) (5-metil-6-(((2r, 6s)-6-(p-tolil)tetrahidro-2h-piran-2-il) metilamino) pirimidin-4-il) metanona.
US11944624B2 (en) * 2017-07-06 2024-04-02 Case Western Reserve University Peptide and small molecule agonists of EphA and their uses

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3663706A (en) 1969-09-29 1972-05-16 Pfizer Use of 2,4-diaminoquinazolines as hypotensive agents
JPS536156B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1972-10-30 1978-03-04
US3935213A (en) 1973-12-05 1976-01-27 Pfizer Inc. Process for hypotensive 4-amino-2-(piperazin-1-yl) quinazoline derivatives
US4060615A (en) * 1976-02-18 1977-11-29 Mead Johnson & Company 2-Piperazinyl-6,7-dimethoxyquinazolines
US4001237A (en) * 1976-02-18 1977-01-04 Bristol-Myers Company Oxazole, isoxazole, thiazole and isothiazole amides
US4189484A (en) * 1977-11-08 1980-02-19 Mitsubishi Yuka Pharmaceutical Co., Ltd. Antihypertensive quinazoline derivatives
US4287341A (en) 1979-11-01 1981-09-01 Pfizer Inc. Alkoxy-substituted-6-chloro-quinazoline-2,4-diones
JPS5728576A (en) * 1980-07-24 1982-02-16 Toshiba Corp Inverter device

Also Published As

Publication number Publication date
FR2475548B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1983-06-24
FR2475548A1 (fr) 1981-08-14
DE3105330C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1991-07-25
GB2068961B (en) 1983-11-30
IT1172225B (it) 1987-06-18
NL191208C (nl) 1995-03-16
CA1154765A (en) 1983-10-04
NL191208B (nl) 1994-10-17
NL8100726A (nl) 1981-09-16
US4426382A (en) 1984-01-17
GB2068961A (en) 1981-08-19
CH644857A5 (de) 1984-08-31
ES8207169A1 (es) 1982-09-01
DE3105330A1 (de) 1981-12-17
IT8167213A0 (it) 1981-02-13

Similar Documents

Publication Publication Date Title
ES499377A0 (es) Un procedimiento para la preparacion de nuevos derivados de piperazinilquinazolina y de homopiperazinilquinazolina hi- pertensora con acticidad.
ES504291A0 (es) Un procedimiento para la preparacion de benzotio-en y benzofuransulfonamidas.
ES506661A0 (es) Un procedimiento para la preparacion de nuevos derivados de la sacarosa industrialmente utiles.
ES508286A0 (es) Un procedimiento para la preparacion de derivados de imidazolil-propanol.
ES506969A0 (es) Un procedimiento para la preparacion de pirimidinas sustitu-idas.
ES501645A0 (es) Un procedimiento para la preparacion de 6-alquiliden-penamas.
ES516472A0 (es) Un procedimiento para la preparacion de derivados de 2-fenileta-nolamina.
ES505464A0 (es) Un procedimiento para la preparacion de n-heterociclilaminocarbonil arilsulfonamidas.
ES524271A0 (es) Un procedimiento para la preparacion de nuevos derivados de daunorrubicina y doxorrubicina.
ES519057A0 (es) Un procedimiento para la preparacion de derivados de caprolactama.
ES505922A0 (es) Un procedimiento para la preparacion de nuevos derivados de cefalospirina.
ES515158A0 (es) Un procedimiento para la preparacion de 2-guanidino-4-heteroariltiazoles.
ES507509A0 (es) Un procedimiento para la preparacion de imidazolilfenilamidinas.
ES503307A0 (es) Un procedimiento para la preparacion de quinoxaliniloxieteres.
ES504790A0 (es) Un procedimiento para la preparacion de derivados de enantolactama.
ES501339A0 (es) Un procedimiento para la preparacion de derivados de 9-carbamoil-9-aminoalquilfluoreno.
ES504793A0 (es) Un procedimiento para la preparacion de nuevos derivados de caprilolactama.
ES503015A0 (es) Un procedimiento para la preparacion de nuevos derivados delindeno.
ES507482A0 (es) Un procedimiento para la preparacion de nuevos derivados de acilaminoquimazolina.
ES505920A0 (es) Un procedimiento para la preparacion de derivados de isonicotinanilida.
ES504577A0 (es) Un procedimiento para la preparacion de derivados de piridazinona.
ES503338A0 (es) Un procedimiento para la preparacion de derivados de bis-hidroxibencilo.
ES507045A0 (es) Un procedimientpo para la preparacion de nuevos derivados de carbamoiloxiisoxazol.
ES500870A0 (es) Un procedimiento para la preparacion de nuevos derivados de triariltiazol.
ES507919A0 (es) Un procedimiento para la preparacion de benzopiranotriazoles antialergicos.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970612